• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

常规成釉细胞瘤的外科治疗:过去 21 年的回顾性队列研究。

Surgical management of conventional ameloblastoma: a retrospective cohort study over the past 21 years.

机构信息

Department of Oral Surgery and Pathology, School of Dentistry, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Minas Gerais, Brazil.

Medical School, Faculdade Ciências Médicas de Minas Gerais, Belo Horizonte, Brazil.

出版信息

Oral Maxillofac Surg. 2024 Nov 4;29(1):4. doi: 10.1007/s10006-024-01296-1.

DOI:10.1007/s10006-024-01296-1
PMID:39495234
Abstract

Conventional ameloblastoma presents infiltrative behavior and its treatment ranges from enucleation combined with adjuvant therapies to marginal/segmental resection. The purpose of this study is to present a cohort of twenty-four patients with ameloblastoma treated in the same institution after marginal/segmental resection for the past 21 years. All cases had diagnosis confirmation by incisional biopsy. Patients with an unconfirmed diagnosis and missing follow-up information were excluded. Data were categorized into clinicopathological, surgical and recurrence aspects. Thirteen patients were females (54%). The mean age was 40.2 years. Mandible was the most affected site (91%). The mean length of the lesions was 4.10 cm (± 2.06) and the multilocular aspect was predominant (83%). Root resorption (37.5%), tooth displacement (45.8%) and cortical perforation (45.8%) were noticed. Histologically, most of the cases were follicular (n = 19,79%). Microscopic analysis showed positive margins in four cases. Patients were treated by marginal (n = 19) and segmental (n = 5) resections. Recurrence occurred in two cases (8.33%). Both primary and recurrent ameloblastomas were treated through marginal resections and no recurrence was observed during the past 9 and 5 years after the last intervention, respectively. The overall mean follow-up was 79.25 months and patients are still monitored over these years. Marginal/segmental resection of conventional ameloblastoma is associated with a low recurrence rate.

摘要

传统型成釉细胞瘤呈浸润性生长,其治疗方法范围从肿瘤剜除术联合辅助治疗到边缘/节段切除术。本研究的目的是报告过去 21 年在同一机构接受边缘/节段切除术治疗的 24 例成釉细胞瘤患者的队列。所有病例均通过切开活检确诊。排除未确诊和随访信息缺失的病例。数据分为临床病理、手术和复发方面。13 例为女性(54%)。平均年龄为 40.2 岁。下颌骨是最常受影响的部位(91%)。病变的平均长度为 4.10 cm(±2.06),多房型为主(83%)。发现根吸收(37.5%)、牙齿移位(45.8%)和皮质穿孔(45.8%)。组织学上,大多数病例为滤泡型(n=19,79%)。显微镜下分析显示 4 例有阳性切缘。患者接受了边缘(n=19)和节段(n=5)切除术治疗。2 例(8.33%)发生复发。原发性和复发性成釉细胞瘤均通过边缘切除术治疗,末次干预后 9 年和 5 年分别未见复发。总的平均随访时间为 79.25 个月,这些年来患者仍在接受监测。传统型成釉细胞瘤的边缘/节段切除术复发率低。

相似文献

1
Surgical management of conventional ameloblastoma: a retrospective cohort study over the past 21 years.常规成釉细胞瘤的外科治疗:过去 21 年的回顾性队列研究。
Oral Maxillofac Surg. 2024 Nov 4;29(1):4. doi: 10.1007/s10006-024-01296-1.
2
Clinicopathologic Profile and Surgical Modalities in Mandibular Ameloblastoma: A Descriptive Study.下颌骨造釉细胞瘤的临床病理特征和手术方式:一项描述性研究。
J Craniofac Surg. 2024;35(1):158-162. doi: 10.1097/SCS.0000000000009706. Epub 2023 Sep 8.
3
What Is Important for Confirming Negative Margins When Resecting Mandibular Ameloblastomas?下颌成釉细胞瘤切除时,确认切缘阴性的关键因素有哪些?
J Oral Maxillofac Surg. 2017 Jun;75(6):1185-1190. doi: 10.1016/j.joms.2016.11.016. Epub 2016 Nov 24.
4
Surgical treatment of recurring ameloblastoma, are there options?复发性成釉细胞瘤的外科治疗,有哪些选择?
Br J Oral Maxillofac Surg. 2013 Dec;51(8):762-6. doi: 10.1016/j.bjoms.2013.08.013. Epub 2013 Sep 16.
5
Surgical Resection and Reconstruction of Ameloblastoma: A 13-Year Retrospective Review.《成釉细胞瘤的外科切除与重建:一项 13 年回顾性研究》
J Oral Maxillofac Surg. 2024 Jul;82(7):862-868. doi: 10.1016/j.joms.2024.03.030. Epub 2024 Apr 1.
6
A clinical, radiographic, and histologic review of 73 cases of ameloblastoma in an Indian population.对印度人群中73例成釉细胞瘤的临床、影像学和组织学回顾。
Quintessence Int. 2010 May;41(5):e90-100.
7
Ameloblastoma of the jaws: Management and recurrence rate.颌骨成釉细胞瘤:治疗与复发率
Eur Ann Otorhinolaryngol Head Neck Dis. 2017 Feb;134(1):7-11. doi: 10.1016/j.anorl.2016.09.004. Epub 2016 Oct 25.
8
Management of primary ameloblastoma of the jaw: a 15 years' experience.颌骨原发性成釉细胞瘤的治疗:15年经验
Minerva Stomatol. 2012 May;61(5):175-82.
9
Recurrent ameloblastoma following osseous reconstruction--a review of twenty years.骨重建后复发性成釉细胞瘤——二十年回顾
J Craniomaxillofac Surg. 2009 Jan;37(1):36-41. doi: 10.1016/j.jcms.2008.07.009. Epub 2008 Nov 20.
10
Ameloblastoma in children and adolescents.儿童和青少年的成釉细胞瘤
Br J Oral Maxillofac Surg. 2010 Oct;48(7):549-54. doi: 10.1016/j.bjoms.2009.08.020. Epub 2009 Sep 24.

本文引用的文献

1
Analysis of BRAF V600E expression and disease-free survival in patients with ameloblastoma.成釉细胞瘤患者BRAF V600E表达与无病生存期分析
Int J Oral Maxillofac Surg. 2022 Aug;51(8):1034-1042. doi: 10.1016/j.ijom.2021.12.011. Epub 2022 Jan 5.
2
Ameloblastoma of the maxillary sinus: conservative surgical management considering high recurrence risk potential.上颌窦造釉细胞瘤:考虑到高复发风险,采用保守的手术治疗。
BMJ Case Rep. 2021 May 13;14(5):e241487. doi: 10.1136/bcr-2020-241487.
3
BRAF p.V600E status in epithelial areas of ameloblastoma with different histological aspects: Implications to the clinical practice.
成釉细胞瘤不同组织学形态上皮区域 BRAF p.V600E 状态:对临床实践的影响。
J Oral Pathol Med. 2021 May;50(5):478-484. doi: 10.1111/jop.13155. Epub 2021 Jan 18.
4
Controversies in ameloblastoma management: evaluation of decision making, based on a retrospective analysis.成釉细胞瘤治疗的争议:基于回顾性分析的决策评估。
Med Oral Patol Oral Cir Bucal. 2021 Mar 1;26(2):e181-e186. doi: 10.4317/medoral.24104.
5
Risk factors for recurrence of ameloblastoma: a long-term follow-up retrospective study.成釉细胞瘤复发的危险因素:一项长期随访的回顾性研究。
Int J Oral Maxillofac Surg. 2019 Oct;48(10):1300-1306. doi: 10.1016/j.ijom.2019.04.008. Epub 2019 May 11.
6
Sinonasal Ameloblastoma.鼻窦成釉细胞瘤
Head Neck Pathol. 2019 Jun;13(2):247-250. doi: 10.1007/s12105-018-0933-3. Epub 2018 May 30.
7
Marsupialization of mandibular cystic ameloblastoma: Retrospective study of 7 years.下颌骨囊型成釉细胞瘤的袋形术治疗:7 年回顾性研究。
Head Neck. 2018 Oct;40(10):2172-2180. doi: 10.1002/hed.25212. Epub 2018 May 13.
8
Ameloblastoma: current etiopathological concepts and management.成釉细胞瘤:当前的病因病理概念和治疗方法。
Oral Dis. 2018 Apr;24(3):307-316. doi: 10.1111/odi.12646. Epub 2017 Mar 9.
9
"Evaluation of safety margin" in ameloblastoma of the mandible by surgical, radiological, and histopathological methods: An evidence-based study.采用手术、放射学和组织病理学方法对下颌骨成釉细胞瘤“安全切缘”的评估:一项循证研究
J Pharm Bioallied Sci. 2016 Oct;8(Suppl 1):S122-S125. doi: 10.4103/0975-7406.191940.
10
Recurrence rate following treatment for primary multicystic ameloblastoma: systematic review and meta-analysis.原发性多囊性成釉细胞瘤治疗后的复发率:系统评价与荟萃分析。
Int J Oral Maxillofac Surg. 2016 Mar;45(3):359-67. doi: 10.1016/j.ijom.2015.12.016. Epub 2016 Jan 11.